Company Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 05/12/2025 GMT			5-day change	1st Jan Change
28.13 ^USD	+1.15%		+1.52%	-13.55%

11-13	Legend Biotech Corporation Celebrates Official Opening of New Cell Therapy Research and Development Facility in Philadelphia	CI
11-13	RBC Trims Price Target on Legend Biotech to $74 From $75, Keeps Outperform Rating	MT

Business description: Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Number of employees: 2,900

Sales by Activity: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024
Biotechnology	78.75M	91.56M	117M	285M	627M

See all business segments

Geographical breakdown of sales: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024
United States of America	-	86.37M	117M	270M	579M
Europe	-	-	-	15.07M	47.87M
China	-	3.42M	328K	179K	320K
North America	75.68M	-	-	-	-
Other	-	-	75K	-	-

See all geographic segments

Executive Committee: Legend Biotech Corporation

Manager	Title	Age	Since
Ying Huang CEO	Chief Executive Officer	52	20/09/2020
Mythili Koneru CTO	Chief Tech/Sci/R&D Officer	47	10/04/2023
Tracy Luo CTO	Chief Tech/Sci/R&D Officer	-	30/04/2018
Guowei Fang CTO	Chief Tech/Sci/R&D Officer	-	28/02/2022
Jessie Yeung DFI	Director of Finance/CFO	40	01/01/2025

See LEGEND BIOTECH CORPORATION governance

Composition of the Board of Directors: Legend Biotech Corporation

Director	Title	Age	Since
Ye Wang CHM	Chairman	56	05/11/2020
Ying Huang BRD	Director/Board Member	52	29/12/2021
Corazon Sanders BRD	Director/Board Member	68	30/04/2020
Xiao Hui Ji BRD	Director/Board Member	63	30/04/2020
Wai Man Yau BRD	Director/Board Member	49	30/04/2020
Li Zhu BRD	Director/Board Member	75	22/11/2020
Patrick Casey BRD	Director/Board Member	69	02/12/2020
Fang Liang Zhang CHM	Chairman	60	26/05/2015
Tomas Jan Heyman BRD	Director/Board Member	69	01/08/2022
Li Mao BRD	Director/Board Member	68	01/08/2022

Composition of the Board of Directors

Shareholders: Legend Biotech Corporation

Name	Equities	%	Valuation
Fidelity Management & Research Co. LLC 15.01 %	27,702,842	15.01 %	898 M $
Westfield Capital Management Co. LP 3.302 %	6,094,486	3.302 %	197 M $
HHLR Advisors Ltd. (Cayman Islands) 3.242 %	5,984,550	3.242 %	194 M $
Suvretta Capital Management LLC 2.069 %	3,818,009	2.069 %	124 M $
BlackRock Advisors LLC 1.94 %	3,581,535	1.94 %	116 M $

Name	Equities	%	Valuation
GENSCRIPT BIOTECH CORPORATION 60.32 %	174,497,556	60.32 %	2 827 M $
Aquapoint LP 10.47 %	30,300,000	10.47 %	491 M $
Fang Liang Zhang 0.369 %	1,067,386	0.369 %	17 M $
Ying Huang 0.0741 %	214,364	0.0741 %	3 M $
Ye Wang 0.0583 %	168,642	0.0583 %	3 M $

List of LEGEND BIOTECH CORPORATION shareholders

Company details: Legend Biotech Corporation

Legend Biotech Corp.

2101 Cottontail Lane

08873, Somerset

+737 317 5050

http://www.legendbiotech.com

address Legend Biotech Corporation(LEGN)

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
LEGEND BIOTECH CORPORATION	+1.15%	+1.52%	-32.48%	-44.83%	5.14B
ARGENX SE	-2.68%	-2.50%	+30.72%	+100.21%	56.54B
INSMED INCORPORATED	-0.51%	-1.81%	+170.81%	+925.64%	43.73B
WUXI APPTEC CO., LTD.	+0.90%	-1.95%	+75.60%	+16.34%	37.82B
BIONTECH SE	+0.26%	-6.69%	-19.01%	-42.27%	23.08B
GENMAB A/S	-1.45%	+0.05%	+32.94%	-37.99%	19.82B
WUXI BIOLOGICS (CAYMAN) INC.	-0.97%	+4.22%	+93.94%	-37.03%	17.43B
SUMMIT THERAPEUTICS INC.	-2.66%	+2.35%	+4.51%	+2,232.48%	14.51B
AKESO, INC.	+0.57%	-1.19%	+86.62%	+286.60%	14.61B
MADRIGAL PHARMACEUTICALS, INC.	-1.52%	-3.30%	+84.41%	+692.23%	13.31B
Average	-0.68%	+0.11%	+52.81%	+409.14%	24.6B
Weighted average by Cap.	-0.95%	-0.23%	+65.88%	+365.64%